Immunosuppressant

Home > API Products > Immunosuppressant
Everolimus

Everolimus

  • Category Anticancer/Immunosuppressant
  • CAS 159351-69-6
  • Specification EP/USP
  • US DMF 26819/27216
  • CEP / Other DMF CEP/EDMF
  • GMP certification TFDA
  • Inspection TFDA
  • StatusCommercial
  • Major Market USA, EU